Thrombin Generation in the Glasgow Myocardial Infarction Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Smid, Machiel ^a   Dielis, Arne W J H ^a   Spronk, Henri M H ^a   Rumley, Ann ^b   van Oerle, Rene ^a   Woodward, Mark ^c   ten Cate, Hugo ^a   Lowe, Gordon ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THROMBIN; THROMBOMODULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SMOKING;

FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS; SCOTLAND; THROMBIN; THROMBOPLASTIN;

EID: 84879491818     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066977     Document Type: Article

References (20)

1. Borissoff JI, Spronk HMH, Cate ten H, (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364: 1746-1760 doi:10.1056/NEJMra1011670.
2. Lowe G (2006) Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture- Lowe- 2006- British Journal of Haematology- Wiley Online Library. Br J Haematol.
3. Smid M, Dielis AWJH, Winkens M, Spronk HMH, van Oerle R, et al. (2011) Thrombin generation in patients with a first acute myocardial infarction. J Thromb Haemost 9: 450-456 doi:10.1111/j.1538-7836.2010.04162.x.
4. Lowe GDO, Woodward M, Rumley A, Morrison CE, Nieuwenhuizen W, (2003) Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction. J Thromb Haemost 1: 2312-2316.
5. Woodward M, Rumley A, Rumley A, Rumley C, Lewington S, et al. (2006) The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study. Blood Coagul Fibrinolysis 17: 1-5 doi:10.1097/01.mbc.0000195919.71950.f7.
6. Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H, (1997) Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 314: 541-546.
7. Spronk HMH, Dielis AWJH, Panova-Noeva M, van Oerle R, Govers-Riemslag JWP, et al. (2009) Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 101: 1156-1162.
8. Dielis AWJH, Castoldi E, Spronk HMH, van Oerle R, Hamulyák K, et al. (2008) Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 6: 125-131 doi:10.1111/j.1538-7836.2007.02824.x.
9. Spronk HMH, Dielis AWJH, de Smedt E, van Oerle R, Fens D, et al. (2008) Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost 100: 362-364.
10. Winckers K, Siegerink B, Duckers C, Maurissen LF, Tans G, et al. (2011) Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study. J Thromb Haemost 9: 2243-2250 doi:10.1111/j.1538-7836.2011.04497.x.
11. Beijers HJBH, Ferreira I, Spronk HMH, Bravenboer B, Dekker JM, et al. (2010) Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arterioscler Thromb Vasc Biol 30: 2639-2647 doi:10.1161/ATVBAHA.110.211946.
12. Daae LN, Kierulf P, Landaas S, Urdal P (1993) Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis. Scand J Clin Lab Invest Suppl 215: 19-27.
13. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RA, (2013) Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol 2013 260: 590.
14. Macchia A, Laffaye N, Comignani PD, Igarzbal C, Scazziota AS, et al. (2012) Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial. PLoS One. 2012 7(3): e32894.
15. Mobarrez F, He S, Bröijersen A, Wiklund B, Antovic A, et al. (2011) Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost. 2011 106(2): 344-52.
16. Undas A, Brummel-Ziedins KE, Mann KG (2005) Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005 Feb; 25(2): 287-94. Review.
17. Brozović M, Gurd LJ, Robertson I, Bangham DR, (1971) Stability of prothrombin and factor VII in freeze-dried plasma. J Clin Pathol 24: 690-693.
18. Koerner K, Stampe D, (1984) Stability of blood coagulation factors in deep frozen fresh plasma by storage at -20 degrees C and -40 degrees C. Infusionsther Klin Ernahr. 1984 11(1): 46-50.
19. Dargaud Y, Luddington R, Gray E, Negrier C, Lecompte T, et al. (2007) Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 139: 303-309 doi:10.1111/j.1365-2141.2007.06785.x.
20. van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, et al. (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 19: 183-189 doi:10.1097/MBC.0b013e3282f4bb47.